OSUR — ORASURE TECHNOLOGIES INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1116463 ·
Last close
$3.93
Market Cap
$271.05M
52W High
$4.58
52W Low
$2.08
ADV30
519,673
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 27,925,000 | 11,804,000 | -23,176,000 | -22,377,000 | 379,169,000 | 176,964,000 | 65,845,000 |
| Dec 2025 | 26,763,000 | 10,968,000 | -16,852,000 | -19,286,000 | 403,168,000 | 199,278,000 | 62,341,000 |
| Sep 2025 | 27,085,000 | 11,772,000 | -15,714,000 | -13,712,000 | 423,098,000 | 216,478,000 | 61,118,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-43,185,000
Investing CF
$-8,093,000
Financing CF
$-22,273,000
CapEx
$-4,690,000
Dividends Paid
—
Buybacks
$-22,203,000
EPS Diluted TTM
$-1.04
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-194,539,000
Inventory
$30,307,000
Receivables
$26,415,000
ST Investments
—
EBIT TTM
$-73,035,000
Pretax Income TTM
$-70,335,000
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$112,412,000
EBITDA
$-61,556,000
Free Cash Flow
$-44,569,624
Enterprise Value
$75,660,040
Total Cash
$160,582,000
Total Debt
$12,094,000
Shares Out
68,968,627
Trailing EPS
$-0.69
Book Value
$4.61
ROE
-14.1%
ROA
-11.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 115,021,000 | -68,124,000 | -68,731,000 | 403,168,000 | 62,341,000 | 340,827,000 | -49,023,000 |
| Dec 2024 | 185,827,000 | -23,858,000 | -19,500,000 | 479,659,000 | 69,321,000 | 410,338,000 | 27,374,000 |
| Dec 2023 | 405,472,000 | 43,414,000 | 53,655,000 | 482,845,000 | 52,174,000 | 430,671,000 | 141,583,000 |
| Dec 2022 | 387,479,000 | -5,243,000 | -17,133,000 | 444,180,000 | 79,755,000 | 364,425,000 | -47,202,000 |
TTM Snapshot
Revenues TTM
$275,496,000
NetIncome TTM
$-3,793,000
OpCashFlow TTM
$0
Assets (Latest)
$403,168,000
Forward EPS
$-0.66
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $5.00 · spot: $3.99 · call volume: 121 · put volume: 52
Expected Move to 2027-01-15:
±$1.57
(39.47%) —
implied range
$2.42 –
$5.57
· ATM straddle on $5.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ANIK | Anika Therapeutics, Inc. | $272.61M | $20.37 | — |
| TLSI | TriSalus Life Sciences, Inc. | $267.23M | $4.34 | — |
| INFU | InfuSystem Holdings, Inc | $253.15M | $12.71 | — |
| TMCI | TREACE MEDICAL CONCEPTS, INC. | $292.66M | $4.50 | — |
| MOBI | Mobia Medical, Inc. | $301.62M | $9.06 | — |
News headlines (Yahoo Finance, 1h cache)
OraSure (OSUR) Returns To Profit, But Growth Remains Elusive
2026-09-06 11:48 · Yahoo
OraSure (OSUR) Q2 2026 Earnings Call Transcript
2026-08-13 00:15 · Yahoo
OraSure Technologies Q2 Earnings Call Highlights
2026-08-06 04:03 · Yahoo
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
2026-06-11 12:00 · Yahoo
OraSure Technologies, Inc. Q1 2026 Earnings Call Summary
2026-05-07 12:30 · Yahoo
OraSure (OSUR) Q1 2026 Earnings Transcript
2026-05-06 22:47 · Yahoo
OraSure Technologies Q1 Earnings Call Highlights
2026-05-07 03:06 · Yahoo
OraSure Announces First Quarter 2026 Financial Results
2026-05-06 20:05 · Yahoo
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
2026-04-22 20:10 · Yahoo
OraSure Technologies, Inc. Q2 2026 Earnings Call Summary
2026-08-06 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.